International Consolidated Airlines Group (ICAGY)
(Delayed Data from OTC)
$4.50 USD
-0.04 (-0.83%)
Updated May 9, 2024 10:15 AM ET
1-Strong Buy of 5 1
B Value F Growth F Momentum D VGM
Price, Consensus and EPS Surprise
ICAGY 4.50 -0.04(-0.83%)
Will ICAGY be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for ICAGY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ICAGY
Are Transportation Stocks Lagging GATX (GATX) This Year?
Best Value Stocks to Buy for May 1st
ICAGY: What are Zacks experts saying now?
Zacks Private Portfolio Services
International Consolidated Airlines Group SA (ICAGY)'s Technical Outlook is Bright After Key Golden Cross
Is International Consolidated Airlines Group (ICAGY) Stock Undervalued Right Now?
Should Value Investors Buy International Consolidated Airlines Group (ICAGY) Stock?
Other News for ICAGY
LONDON MARKET CLOSE: Shares rise as eyes turn to Bank of England
UK earnings, trading statements calendar - next 7 days
LONDON MARKET MIDDAY: FTSE 100 hits record again ahead of BoE call
International Consolidated Airlines: Significant Capital Gains Possible For The Patient Investor
UK earnings, trading statements calendar - next 21 days